BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 21548736)

  • 41. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.
    Onaitis MW; Kalady MF; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Surgery; 2003 Aug; 134(2):300-5. PubMed ID: 12947333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells.
    Jung JY; Roberts LL; Robinson CM
    Immunology; 2015 Apr; 144(4):649-60. PubMed ID: 25346485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro.
    Vujanovic L; Ranieri E; Gambotto A; Olson WC; Kirkwood JM; Storkus WJ
    Cancer Gene Ther; 2006 Aug; 13(8):798-805. PubMed ID: 16645618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adhesive substrates modulate the activation and stimulatory capacity of non-obese diabetic mouse-derived dendritic cells.
    Acharya AP; Dolgova NV; Xia CQ; Clare-Salzler MJ; Keselowsky BG
    Acta Biomater; 2011 Jan; 7(1):180-92. PubMed ID: 20807596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic cells transfected with lentiviral vector-encoding hTERT peptide augment antitumor T cell response in vitro.
    Cui J; Cui L; Liu Q; Sun Q
    Mol Med Rep; 2012 Jan; 5(1):103-7. PubMed ID: 21971748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions.
    Peng JC; Hyde C; Pai S; O'Sullivan BJ; Nielsen LK; Thomas R
    J Immunother; 2006; 29(6):606-15. PubMed ID: 17063123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects.
    Chang MC; Lee CN; Chen YL; Chiang YC; Sun WZ; Hu YH; Chen CA; Cheng WF
    Clin Sci (Lond); 2012 Sep; 123(6):347-60. PubMed ID: 22264240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
    Tüting T; Wilson CC; Martin DM; Kasamon YL; Rowles J; Ma DI; Slingluff CL; Wagner SN; van der Bruggen P; Baar J; Lotze MT; Storkus WJ
    J Immunol; 1998 Feb; 160(3):1139-47. PubMed ID: 9570527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale.
    Kaka AS; Foster AE; Weiss HL; Rooney CM; Leen AM
    J Immunother; 2008 May; 31(4):359-69. PubMed ID: 18391760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficient genetic modification of murine dendritic cells by electroporation with mRNA.
    Van Meirvenne S; Straetman L; Heirman C; Dullaers M; De Greef C; Van Tendeloo V; Thielemans K
    Cancer Gene Ther; 2002 Sep; 9(9):787-97. PubMed ID: 12189529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5.
    Le Gallo M; Toutirais O; Montier T; Cabillic F; Bouet F; Delépine P; Lehn P; Jotereau F; Catros V
    J Gene Med; 2008 Jun; 10(6):628-36. PubMed ID: 18338820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
    Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY
    Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
    Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
    J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The response of human dendritic cells to recombinant adenovirus, recombinant Mycobacterium bovis Bacillus Calmette Guerin and biolistic methods of antigen delivery: different induction of contact-dependant and soluble signals.
    Smith SG; Patel PM; Selby PJ; Jackson AM
    Immunol Lett; 2001 Mar; 76(2):79-88. PubMed ID: 11274724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro.
    Tao R; Li L; Huang W; Zheng L
    Hum Gene Ther; 2010 Jan; 21(1):98-108. PubMed ID: 19715401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells.
    Mehrotra S; Chhabra A; Chakraborty A; Chattopadhyay S; Slowik M; Stevens R; Zengou R; Mathias C; Butterfield LH; Dorsky DI; Economou JS; Mukherji B; Chakraborty NG
    Immunology; 2004 Dec; 113(4):472-81. PubMed ID: 15554925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.
    Schaft N; Dörrie J; Thumann P; Beck VE; Müller I; Schultz ES; Kämpgen E; Dieckmann D; Schuler G
    J Immunol; 2005 Mar; 174(5):3087-97. PubMed ID: 15728524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction.
    Sonderbye L; Feng S; Yacoubian S; Buehler H; Ahsan N; Mulligan R; Langhoff E
    Exp Clin Immunogenet; 1998; 15(2):100-11. PubMed ID: 9691204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.